Company intelligence / Profile preview

Special Alloy

Boston, Massachusetts, United Statesspecialalloyfab.com ↗

Ownership: Private
Employees: ~125
Development stage: Commercial

Overview

Alloy Therapeutics does not develop its own drugs but provides foundational technologies and integrated services for therapeutic biologic discovery across multiple modalities. Its platforms have enabled over 170 partners with more than 60 licensed programs and at least nine antibodies in clinical development through partner pipelines.

Modalities: Monoclonal antibodyBispecific monoclonal antibodyT cell receptor mimic antibody (TCRm)Antisense oligonucleotidePeptidesCell therapyDrug delivery platform
Industry: Drug Discovery Services

Partnerships

Eli Lilly/Lilly Catalyze360™PfizerNumerous biopharma companies (>170 partnerships), including many Fortune 50 biopharmaceutical firms

Beyond the preview

Go deeper on Special Alloy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Special Alloy.

Explore the full profile